Seeing Is Believing
Healthcare - Sector
HCAT is currently covered by 10 analysts with an average price target of $2.52. This is a potential upside of $3 (64.71%) from yesterday's end of day stock price of $1.53.
Health Catalyst's activity chart (see below) currently has 187 price targets and 165 ratings on display. The stock rating distribution of HCAT is 32% BUY and 68% HOLD.
Analysts average stock forecasts to be materialized ratio is 35.84% with an average time for these price targets to be met of 93.06 days.
Highest price target for HCAT is $4, Lowest price target is $1.5, average price target is $2.52.
Most recent stock forecast was given by RICHARD CLOSE from CANACCORD on 20-Aug-2026. First documented stock forecast 18-Aug-2019.
Currently out of the existing stock ratings of HCAT, 8 are a BUY (32%), 17 are a HOLD (68%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Apr-2020
$1.8
$0.27 (17.65%)
$3
Hold Since 25-Jun-2026
$1.5
$-0.03 (-1.96%)
$1.75
Hold Since 10-Nov-2025
$2
$0.47 (30.72%)
$1.75
Hold Since 08-Aug-2024
$1.75
$-0.15 (-7.89%)
$2
Hold Since 09-Sep-2025
$3
What is HCAT (Health Catalyst) average time for price targets to be met?
Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?
Which analyst has the most public recommendations on HCAT (Health Catalyst)?
Which analyst is the currently most bullish on HCAT (Health Catalyst)?
Which analyst is the currently most reserved on HCAT (Health Catalyst)?